Literature DB >> 9400497

Expression of transforming growth factor alpha and epidermal growth factor receptor in adult polycystic kidney disease.

D C Lee1, K W Chan, S Y Chan.   

Abstract

Adult polycystic kidney disease (APKD) is a common genetic disease with a frequency of 1:1000. Evidence suggests that transforming growth factor alpha (TGF alpha) signaling may contribute to the hyperproliferation of the cystic epithelia in APKD. TGF alpha and epidermal growth factor (EGF) are well known mitogens expressed in the kidney and both exert their biological activities through binding to the same EGF receptor. A transgenic mouse that over-expressed TGF alpha developed renal cysts; raised levels of TGF alpha and EGF receptor mRNA were found in kidneys from two autosomal dominant APKD patients. To study the role of TGF alpha in cyst formation, we analyzed nine anatomically diagnosed adult polycystic kidneys and four normal kidneys using immunohistochemistry. We also traced the possible origins of the cysts by staining with the proximal convoluted tubule (PCT) marker, gp330, and the distal convoluted tubule (DCT) and collecting tubule (CT) marker, peanut agglutinin (PNA). In normal kidneys, TGF alpha protein was concentrated in the DCT and CT and EGF receptor protein in all three tubule types. In the early cysts of APKD, the cystic epithelia showed strong positive staining with TGF alpha, EGF receptor and gp330 but negative with PNA. Strong TGF alpha and EGF receptor staining was also found in the mixture of advanced cysts in the end-stage cystic kidneys although the cysts are likely to be derived from different segment of the renal tubules. This increased TGF alpha and EGF receptor expression in all cases and all types of cysts suggests that autocrine/paracrine stimulation by TGF alpha may be a common mechanism in cyst development in APKD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9400497     DOI: 10.1016/s0022-5347(01)64084-9

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

Review 1.  Potential pharmacological interventions in polycystic kidney disease.

Authors:  Amirali Masoumi; Berenice Reed-Gitomer; Catherine Kelleher; Robert W Schrier
Journal:  Drugs       Date:  2007       Impact factor: 9.546

2.  Transforming growth factor alpha (TGF-alpha) and other targets of tumor necrosis factor-alpha converting enzyme (TACE) in murine polycystic kidney disease.

Authors:  Raghad Nemo; Noel Murcia; Katherine Macrae Dell
Journal:  Pediatr Res       Date:  2005-03-17       Impact factor: 3.756

3.  Urinary EGF Receptor Ligand Excretion in Patients with Autosomal Dominant Polycystic Kidney Disease and Response to Tolvaptan.

Authors:  Laura R Harskamp; Ron T Gansevoort; Wendy E Boertien; Wim van Oeveren; Gerwin E Engels; Harry van Goor; Esther Meijer
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-31       Impact factor: 8.237

4.  Increased expression of EGFR and TGF-alpha in segmental renal dysplasia in duplex kidney.

Authors:  Valeria Solari; Hideki Shima; Prem Puri
Journal:  Pediatr Surg Int       Date:  2004-04-03       Impact factor: 1.827

Review 5.  Proliferative signaling by ERBB proteins and RAF/MEK/ERK effectors in polycystic kidney disease.

Authors:  Mitchell I Parker; Anna S Nikonova; Danlin Sun; Erica A Golemis
Journal:  Cell Signal       Date:  2019-12-09       Impact factor: 4.315

6.  Bicc1 Polymerization Regulates the Localization and Silencing of Bound mRNA.

Authors:  Benjamin Rothé; Lucia Leal-Esteban; Florian Bernet; Séverine Urfer; Nicholas Doerr; Thomas Weimbs; Justyna Iwaszkiewicz; Daniel B Constam
Journal:  Mol Cell Biol       Date:  2015-07-27       Impact factor: 4.272

Review 7.  Role of epidermal growth factor receptor in acute and chronic kidney injury.

Authors:  Jinhua Tang; Na Liu; Shougang Zhuang
Journal:  Kidney Int       Date:  2013-01-16       Impact factor: 10.612

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.